Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kelly D Moynihan

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
Cancer Research|September 21, 2017
Roles for Innate Immunity in Combination ImmunotherapiesKelly D Moynihan, Darrell J Irvine
Cancer Immunology Research|July 10, 2015
Engineering New Approaches to Cancer VaccinesNaveen K Mehta, Kelly D Moynihan, Darrell J Irvine
Journal of Controlled Release : Official Journal of the Controlled Release Society|October 9, 2017
Radiation-enhanced delivery of systemically administered amphiphilic-CpG oligodeoxynucleotideOliver K Appelbe, Kelly D Moynihan, Amy Flor, et al.
Oncoimmunology|May 10, 2019
Order of administration of combination cytokine therapies can decouple toxicity from efficacy in syngeneic mouse tumor modelsAdrienne Rothschilds, Alice Tzeng, Naveen K Mehta, et al.
Plos One|April 15, 2021
Immunotherapy-induced antibodies to endogenous retroviral envelope glycoprotein confer tumor protection in miceByong H Kang, Noor Momin, Kelly D Moynihan, et al.
Science Immunology|March 20, 2021
Exploiting albumin as a mucosal vaccine chaperone for robust generation of lung-resident memory T cellsKavya Rakhra, Wuhbet Abraham, Chensu Wang, et al.
Nature Communications|January 18, 2017
High-throughput quantitation of inorganic nanoparticle biodistribution at the single-cell level using mass cytometryYu-Sang Sabrina Yang, Prabhani U Atukorale, Kelly D Moynihan, et al.
Nature Communications|August 15, 2017
Erratum: High-throughput quantitation of inorganic nanoparticle biodistribution at the single-cell level using mass cytometryYu-Sang Sabrina Yang, Prabhani U Atukorale, Kelly D Moynihan, et al.
Nature|February 18, 2014
Structure-based programming of lymph-node targeting in molecular vaccinesHaipeng Liu, Kelly D Moynihan, Yiran Zheng, et al.
The Journal of Clinical Investigation|May 5, 2015
Nanoparticulate STING agonists are potent lymph node-targeted vaccine adjuvantsMelissa C Hanson, Monica P Crespo, Wuhbet Abraham, et al.
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Cancer Research|September 21, 2017
Roles for Innate Immunity in Combination ImmunotherapiesKelly D Moynihan, Darrell J Irvine
Cancer Immunology Research|July 10, 2015
Engineering New Approaches to Cancer VaccinesNaveen K Mehta, Kelly D Moynihan, Darrell J Irvine
Journal of Controlled Release : Official Journal of the Controlled Release Society|October 9, 2017
Radiation-enhanced delivery of systemically administered amphiphilic-CpG oligodeoxynucleotideOliver K Appelbe, Kelly D Moynihan, Amy Flor, et al.
Oncoimmunology|May 10, 2019
Order of administration of combination cytokine therapies can decouple toxicity from efficacy in syngeneic mouse tumor modelsAdrienne Rothschilds, Alice Tzeng, Naveen K Mehta, et al.
Plos One|April 15, 2021
Immunotherapy-induced antibodies to endogenous retroviral envelope glycoprotein confer tumor protection in miceByong H Kang, Noor Momin, Kelly D Moynihan, et al.
Science Immunology|March 20, 2021
Exploiting albumin as a mucosal vaccine chaperone for robust generation of lung-resident memory T cellsKavya Rakhra, Wuhbet Abraham, Chensu Wang, et al.
Nature Communications|January 18, 2017
High-throughput quantitation of inorganic nanoparticle biodistribution at the single-cell level using mass cytometryYu-Sang Sabrina Yang, Prabhani U Atukorale, Kelly D Moynihan, et al.
Nature Communications|August 15, 2017
Erratum: High-throughput quantitation of inorganic nanoparticle biodistribution at the single-cell level using mass cytometryYu-Sang Sabrina Yang, Prabhani U Atukorale, Kelly D Moynihan, et al.
Nature|February 18, 2014
Structure-based programming of lymph-node targeting in molecular vaccinesHaipeng Liu, Kelly D Moynihan, Yiran Zheng, et al.
The Journal of Clinical Investigation|May 5, 2015
Nanoparticulate STING agonists are potent lymph node-targeted vaccine adjuvantsMelissa C Hanson, Monica P Crespo, Wuhbet Abraham, et al.
Pageof 3